FIELD: medicine, pharmacy. SUBSTANCE: invention claims a tablet for a single oral administration of drug in colon intestine. Tablet has an internal core at amount 10-45% of tablet mass, surrounding labile polymeric layer and an enterosoluble envelope that surrounds its. Internal core has the biologically active compound and a pharmaceutically acceptable carrier. Labile polymeric layer has 30-85% of tablet mass and its thickness is 2-3.5 mm. It is made of the pharmaceutically acceptable derivative of cellulose ester and viscosity of its 2 wt.-% solution is 3-100 sP. Enterosoluble envelope has 5-25% of tablet mass and its thickness is about 50-300 mcm. Labile polymeric layer can include microcrystalline cellulose additionally at mass ratio of derivative of cellulose ester to microcrystalline cellulose from 6:1 to 0.5:1. The preferable derivative of cellulose ester is hydroxypropylcellulose, hydroxypropylmethylcellulose or their mixture. Invention ensures to deliver drugs in colon intestine without use of enema medicinal forms. EFFECT: enhanced effectiveness of the composition. 5 cl, 3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF INHIBITORS OF GASTRO- INTESTINAL LIPASE | 1998 |
|
RU2201272C2 |
TETRAHYDROLIPSTATIN-CONTAINING COMPOSITIONS | 1998 |
|
RU2170579C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR | 2010 |
|
RU2537224C2 |
PHARMACEUTICAL COMPOSITION CONTAINING LIPASE INHIBITOR AND GLUCOMANNAN | 2003 |
|
RU2297221C2 |
PHARMACEUTICAL COMPOUND | 1994 |
|
RU2141844C1 |
DIPHOSPHONIC ACID-CONTAINING COMPOSITIONS | 1999 |
|
RU2207860C2 |
COMPOSITION WITH HIGH DOSE OF IBANDRONAT | 2003 |
|
RU2315603C2 |
MEDICINAL FORMS ON BASIS OF BIPHOSPHONATES | 2005 |
|
RU2359678C2 |
N-OXYCARBONYL-SUBSTITUTED 5'-DEOXY-5-FLUOROCYTIDINES AND PHARMACEUTICAL PREPARATION | 1993 |
|
RU2493162C1 |
METHOD FOR PREPARING COMPOSITION | 2001 |
|
RU2244542C2 |
Authors
Dates
1999-09-27—Published
1995-03-22—Filed